Skip to content

Company information lookup


Clinical-stage pharmaceutical drug development

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
IVX 0.053 -3.64% 0.053 0.055 0.053 0.055 0.053 352,252


Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code IVX
Official Listing Date 15 February, 2010
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address
Registered Office Address c/- McCullough Robertson Lawyers, Level 11, 66 Eagle Street, Brisbane, QLD, AUSTRALIA, 4000
Head Office Telephone +61 7 3295 0500
Head Office Fax +61 7 3295 0599
Share Registry Telephone 1300 554 474
Directors / Senior Management
Dr Ralph Craven (Chairman)
Dr Greg Collier (Managing Director, CEO)
Dr Mitchell Glass (Executive Director)
Mr Warren Brown (Non Exec. Director)
Dr James Campbell (Non Exec. Director)
Mr Brett Heading (Non Exec. Director)
Company Secretary Ms Melanie Farris
Principal Activities Clinical-stage pharmaceutical drug development

INVION LIMITED announcements

How are company announcements published on

Date Price
Headline Pages PDF
31/10/2014   Annual Report to shareholders 84 PDF
31/10/2014 asterix Appendix 4C - quarterly 5 PDF
20/10/2014   AGM Notice of Meeting and Proxy Form 22 PDF
24/09/2014 asterix Update on 3M collaboration for inhaled INV102 (nadolol) 2 PDF
23/09/2014   Dr Glass discusses asthma trial update with BRR Media 1 PDF
23/09/2014 asterix Phase 2 asthma trial interim blinded data 2 PDF
15/09/2014   Change in substantial holding 2 PDF
08/09/2014   Dr Collier discusses lupus trial update with BRR Media 1 PDF
08/09/2014 asterix Lupus clinical trial update 2 PDF
28/08/2014 asterix Appendix 4E and Full Year Statutory Accounts 70 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
31 Oct 2014 0.053 -3.64% 0.055 0.053 352,252
30 Oct 2014 0.055 0% 0.055 0.053 228,272
29 Oct 2014 0.055 0% 0.056 0.052 576,391
28 Oct 2014 0.055 -8.33% 0.063 0.047 1,044,540
27 Oct 2014 0.060 0% 0.061 0.060 313,642

* Volume of shares shown represents only those shares traded on ASX.

INVION LIMITED price history chart

* More charting options are available.


How are dividends released on

No dividends have been found for the security IVX. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security IVX

Warrants & Structured Products

No warrants & Structured Products are available over the security IVX